FDA Approves Weight Loss Drug Wegovy for Teens The FDA recently approved Wegovy (semaglutide), a GLP-1 receptor agonist, as a weight loss treatment for teens ages 12 and up
More severe issues of GLP-1s can include: Pancreatitis, or severe abdominal pain radiating to the back, and vomiting Bowel obstruction, which consists of severe abdominal pain, vomiting, bloating, and constipation Severe gastroparesis, a chronic condition characterized by delayed stomach emptying without a physical blockage Identifying the Signs of Pancreatitis and Obstruction These can seem similar to many of the common side effects, so its important to know the difference
Semaglutide shouldnt be used for people who just want to lose weight for a holiday or an upcoming event like a wedding
A balanced approach with quality carbohydrates from vegetables, fruits and whole grains is typically more sustainable and nutritionally complete
Probiotics may also reduce bloating and gassiness by supporting a healthy microbiome, although the evidence is limited
For longer travel, portable medication coolers designed for diabetes supplies maintain appropriate temperatures
